It is a healthcare private limited company based in Raipur, Chattisgarh, India, established in 2016.
2016 | Raipur, Chattisgarh, India | ActiveRegalis Life Sciences Private Limited, a active private limited company, was established on 05 July 2016 in Raipur, Chattisgarh, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U24304CT2016PTC007375. Registered under ROC Roc Chhattisgarh. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Komal Chand Chopda (Director), Rishabh Chopda (Director), Ashish Chopda (Director). Past directors included Anil Deshlahara, Chandrashekhar Dubey Rishideo, Rishabh Chopda. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.11, Kedia Business Park, Opposite National Garage, Tatibandh, Raipur, Chattisgarh, 492001.
U24304CT2016PTC007375
007375
05 July 2016
₹1.00 M
₹0.20 M
Roc Chhattisgarh
Unlisted
Active
Explore comprehensive insights into Regalis Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Komal Chand Chopda | Director | 05 Jul 2016 | Current |
| Rishabh Chopda | Director | 12 Oct 2019 | Current |
| Ashish Chopda | Director | 12 Oct 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Nov 2019 | Past |
| Pramod Abcsdd | Additional Director | 25 Feb 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Dec 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Regalis Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 16.87% decrease. The company also saw a substantial fall in profitability, with a 45.29% decrease in profit. The company's net worth Soared by an impressive increase of 59.97%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Regalis Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Regalis Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Regalis Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regalis Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Regalis Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Regalis Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chhattisgarh. was recorded as a recent event.
Progress on Rishabh Chopda was appointed as a Director was appointed as a Director on 12 Oct 2019 & has been associated with this company since 6 years 1 month . was documented.
The activity Ashish Chopda was appointed as a Director was appointed as a Director on 12 Oct 2019 & has been associated with this company since 6 years 1 month . was completed.
The activity Komal Chand Chopda was appointed as a Director was appointed as a Director on 05 Jul 2016 & has been associated with this company since 9 years 4 months . was completed.
Regalis Life Sciences Private Limited was registered on 05 Jul 2016 with Roc Chhattisgarh & aged 9 years 4 months as per MCA records. was recorded as a recent event.
The CIN of Regalis Life Sciences Private Limited is U24304CT2016PTC007375.
Regalis Life Sciences Private Limited is headquartered at Plot No.11, Kedia Business Park, Opposite National Garage, Tatibandh, Raipur, Chattisgarh, 492001.
Regalis Life Sciences Private Limited was incorporated on 05 July 2016.
The current directors of Regalis Life Sciences Private Limited are
The primary industry of Regalis Life Sciences Private Limited is Trade.
Regalis Life Sciences Private Limited is unlisted.
The authorized capital of Regalis Life Sciences Private Limited is ₹1.00 M, and the paid-up capital is ₹0.20 M.
The compliance status of Regalis Life Sciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX